Track topics on Twitter Track topics that are important to you
Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...
Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...
Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...
A recall was initiated by Medtronic involving 3,331 units of its 23- and 25-mm Endurant and Endurant II stent graft systems m -More-
WASHINGTON (Reuters) - Patients who received Abbott Laboratories' novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company's ...
(Reuters Health) - For people with type 2 diabetes, maintaining good blood sugar control in the years after receiving a coronary artery stent is associated with a lower risk of heart attack and stroke...
Higher heart risk seen with Abbott dissolving stent after 2 years -studyDaily MailWASHINGTON, March 18 (Reuters) - Patients who received Abbott Laboratories' novel dissolving vascular stent had a sign...
A recall was initiated by Boston Scientific involving all of its Lotus Valve heart devices in Europe and in US clinical trial -More-
Patients who underwent surgery within 12 months of receiving treatment with a drug-eluting stent by PCI had an increased risk of 30-day MI and cardiac death compared with those who did not receive a s...
The FDA approved the COBRA PzF NanoCoated coronary stent system to improve coronary luminal diameter in certain patients with ischemic heart disease.
Body: Raleigh General Hospital in Beckley, West Virginia, has reached a settlement in dozens of cases that involved a doctor giving unwarranted heart procedures, reports WVVA, an NBC affiliate. T...
To compare the occurrence of acute stent recoil in two different stent types (platinum chromium and cobalt chromium) and identify the potential predictors of significant acute stent recoil.
TCT-70 Final 5 year results from the COMPARE II trial: comparison between the durable polymer coated everolimus-eluting Xience/Promus stent and the biodegradable polymer coated biolimus-eluting Nobori stent in all comer population.